Drug profile · INN
amlodipine besilate
EXFORGE HCT
amlodipine besilate (EXFORGE HCT) is a voltage-gated l-type calcium channel blocker.
EMA: approved Cardiovascular system (C09) C09DX01
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — amlodipine besilate
- Class
- Cardiovascular system (C09)
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.83
Quick answer
amlodipine besilate (EXFORGE HCT) is a voltage-gated l-type calcium channel blocker.
Key facts
INN amlodipine besilate
Brand EXFORGE HCT
Mechanism Voltage-gated L-type calcium channel blocker
Target Voltage-gated L-type calcium channel
Therapeutic class Cardiovascular system (C09)
ATC code C09DX01
Mechanism of action
Voltage-gated L-type calcium channel blocker
Primary target: Voltage-gated L-type calcium channel
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is amlodipine besilate?
amlodipine besilate (EXFORGE HCT) is a voltage-gated l-type calcium channel blocker.
What is the brand name for amlodipine besilate?
EXFORGE HCT is a marketed brand name for amlodipine besilate. Check FDA Drugs@FDA for the current US label holder and prescribing information.